LERCANAPRIL TEVA 1020

Negara: Israel

Bahasa: Inggris

Sumber: Ministry of Health

Bahan aktif:

ENALAPRIL MALEATE; LERCANIDIPINE HYDROCHLORIDE

Tersedia dari:

ABIC MARKETING LTD, ISRAEL

Kode ATC:

C09BB02

Bentuk farmasi:

FILM COATED TABLETS

Komposisi:

LERCANIDIPINE HYDROCHLORIDE 10 MG; ENALAPRIL MALEATE 20 MG

Rute administrasi :

PER OS

Jenis Resep:

Required

Diproduksi oleh:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Area terapi:

ENALAPRIL AND LERCANIDIPINE

Indikasi Terapi:

Treatment of essential hypertension in patients whose blood pressure cannot be adequately controlled under Enalapril monotherapy.

Tanggal Otorisasi:

2020-04-28

Selebaran informasi

PATIENT LEAFLET IN ACCORDANCE
WITH THE PHARMACISTS’
REGULATIONS (PREPARATIONS) –
1986
The medicine is dispensed with a doctor’s
prescription only
Lercanapril Teva 10/10
Film-coated tablets
Lercanapril Teva 10/20
Film-coated tablets
Composition:
Each tablet of Lercanapril Teva 10/10
contains:
Lercanidipine hydrochloride 10 mg and
Enalapril maleate 10 mg.
Each tablet of Lercanapril Teva 10/20
contains:
Lercanidipine hydrochloride 10 mg and
Enalapril maleate 20 mg.
For information regarding inactive ingredients
and allergens, see section 2 – “Important
information about some of the ingredients
of the medicine” and section 6 – “Additional
information”.
Read the entire leaflet carefully before
using the medicine. This leaflet contains
concise information about the medicine. If
you have additional questions, refer to the
doctor or the pharmacist.
This medicine has been prescribed for
treatment of your illness. Do not pass it on
to others. It may harm them even if it seems
to you that their medical condition is similar.
Lercanapril Teva is not intended for
primary treatment of hypertension.
1 .
WHAT
IS
THE
MEDICINE
INTENDED FOR?
•
Lercanapril Teva 10/10 is used for
treatment of hypertension in patients
whose
blood
pressure
cannot
be
adequately controlled through treatment
with lercanidipine alone.
•
Lercanapril Teva 10/20 is used for
treatment of hypertension in patients whose
blood pressure cannot be adequately
controlled through treatment with enalapril
alone.
Therapeutic class:
•
Enalapril belongs to the angiotensin-
converting enzyme inhibitors (ACE
inhibitors) group.
•
Lercanidipine belongs to the calcium
channel blockers group.
2. BEFORE USING THE MEDICINE
Do not use the medicine if:
•
You are sensitive (allergic) to the active
ingredients (enalapril maleate and/or
lercanidipine hydrochloride) or to any
of the other ingredients this medicine
contains (see section 6 – “Additional
information”).
•
You have previously had an allergic
reaction to a type of medicine similar
to those